In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

20202,765 citationsJournal Articlehybrid Open Access

Authors

Hydroxychloroquine was found to be more potent than chloroquine to inhibit SARS-CoV-2 in vitro.

Good health and well-being

Published in: Clinical Infectious Diseases

Volume 71, Issue 15, pp. 732-739

Field-Weighted Citation Impact: 67.68